{"id":"W4249539749","doi":"10.1182/blood.v114.22.1874.1874","title":"Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid®) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Regimen; Thalidomide; Internal medicine; Prednisone; Multiple myeloma; Cyclophosphamide; Gastroenterology; Bortezomib; Surgery; Dexamethasone; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001790515,0.001634129,0.001742918,0.0003641954,0.0003613296,0.0008250264,0.0008629843,0.001170633,0.004213351],"category_scores_gemma":[0.0008094399,0.0006589611,0.0009545429,0.0003674412,0.0009265495,0.0006692908,0.0003711404,0.003381285,0.001110359],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008194115,"about_ca_system_score_gemma":0.001074441,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008808203,"about_ca_topic_score_gemma":0.001950617,"domain_scores_codex":[0.9995679,0.0002373139,0.0000219367,0.00006031819,0.00003281943,0.00007968459],"domain_scores_gemma":[0.9994005,0.00009834341,0.0001096622,0.00004352006,0.00002503364,0.0003230281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8536969,0.05176077,0.004655995,0.0005733764,0.0007193727,0.0003080091,0.0002062526,0.001316408,0.01674581,0.0003239898,0.006181237,0.06351175],"study_design_scores_gemma":[0.8008827,0.1891119,0.005645178,0.00002476352,0.0002116197,0.0001810053,0.00003065595,0.0007728832,0.001119516,0.0001553077,0.001848519,0.00001591007],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848643,0.003135591,0.0004987158,0.00109623,0.0003057542,0.005199535,0.001302682,0.0001334818,0.003463756],"genre_scores_gemma":[0.9807704,0.002628992,0.002080461,0.002032604,0.00041821,0.004153019,0.003309197,0.00003566565,0.004571489],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004213351,"threshold_uncertainty_score":0.01409513,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02313148557455885,"score_gpt":0.2965595289994377,"score_spread":0.2734280434248788,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}